drugset / Trial / NCT00332605

N-Acetyl Cysteine Plus Naltrexone in Methamphetamine Dependence

NCT00332605

Phase 2 Completed 45 enrolled University of Chicago
RandomizedParallel-groupDouble-blindTreatment

Summary

The goal of the proposed study is to evaluate the efficacy and safety of N-Acetyl Cysteine (NAC) in combination with naltrexone in methamphetamine dependence.

Timeline

Start
2006-06
Primary completion
2009-12
Completion
2010-01

Drugs

EvaluationDrugModalityDoseRoute
Subject N-acetylcysteine Small molecule 600 mg
Subject Naltrexone Small molecule